Report of Two Cases with Germinoma Treated by Individual Adjuvant Chemotherapy Based on the mRNA Expression of Drug-resistance Gene

Neurological Surgery

Volumn 32, Issue 1, 2004, Pages 19-26

  Kunishio, Katsuzo ^a,b   Okada, Masaki ^a   Miyake, Keisuke ^a   Matsumoto, Yoshihito ^a   Nagao, Seigo ^a   Nishiyama, Yoshihiro ^a   Ohkawa, Motoharu ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Chemotherapy; Germ cell tumor; MIBI SPECT; Multidrug resistance gene

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; MESSENGER RNA; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; ARTICLE; BRAIN BIOPSY; CASE REPORT; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GERM CELL TUMOR; HUMAN; MALE; MEDULLA OBLONGATA; MULTIDRUG RESISTANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FATAL OUTCOME; GENE EXPRESSION; GENES, MDR; GERMINOMA; HUMANS; IFOSFAMIDE; MALE; PHARMACOGENETICS; RNA, MESSENGER; TREATMENT OUTCOME;

EID: 1042291258     PISSN: 03012603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Andrews DW, Das R, Kim S, Zhang J, Curtis M: Technetium-MIBI as a glioma imaging agent for the assessment of multi-drug resistance. Neurosurgery 40: 1323-32, 1997
2. Beck WT: Unknoting the complexities of multidrug resistance: The involvement of DNA topoisomerase in drug action and resistance. J Natl Cancer Inst 82: 1683-1685, 1980
3. Balmaceda C, Heller G, Rosenblum M, Diez B, Villablanca JG, Kellie S: Chemotherapy without irradiation: a novel approach for newly-diagnosed central nervous system (CNS) germ-cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol 14: 2908-2915, 1996
4. Becker I, Becker KF, Meyermann R, Hollt V: The multidrug-resistance gene MDR1 is expressed in human glial tumors. Acta Neuropathol 82: 516-519, 1991
5. Calaminus G, Bamberg M, Baranzelli MC, Benoit Y, di Montezemolo LC, Fossati-Bellani F, Jurgens H, Kuhl HJ, Lenard HG, Curto ML, Mann JR, Patte C, Pearson A, Perilongo G, Schmidt D, Schober R, Gobel U: Intracranial germ cell tumors: a comprehensive update of the European data. Neuropediatrics 25: 26-32, 1994
6. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG: Overexpression of a transporter gene in a multidrug-resistance human lung cancer cell line. Science 258: 1650-1654, 1992
7. Eid H, Mingfang L, Institoris E, Bodrogi I, Bak M: MRP expression of testicular cancers and its clinical relevance. Anticancer Res 20: 4019-4022, 2000
8. Eid H, Geczi L, Magori A, Bodrogi I, Institoris E, Bak M: Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins. Anticancer Res 18: 3059-3064, 1998
9. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesmann MM, Pastan I: Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci 84: 265-269, 1987
10. Gormley PE, Gangji D, Wood JH, Poplack DG: Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II). Cancer Chemother Pharmacol 5: 257-260, 1981
11. Grant CE, Vadimarsson G, Hipfner DR, Almquist KC, Cole SPC, Deeley RG: Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54: 357-361, 1994
12. Hendrikse NH, Franssen EJ, van der Graaf WT, Meijer C, Piers DA, Vaalburg W, de Vries EG: 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein. Br J Cancer 77: 353-358, 1998
13. Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJT, Juijn JA, Baas F, Borst P: Analysis of expression of cMOAT (MRP2), MRP3, MRP4 and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 57: 3537-3547, 1997
14. Lee JS, Scala S, Matsumoto Y, Dickstein B, Robey R, Zhan Z, Altenberg G, Bates SE: Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression. J Cell Biochem 65: 513-526, 1997
15. Matsumoto Y, Takano H, Fojo T: Cellular adaptation to drug exposure: Evolution of the drug-resistant phenotype. Cancer Res 57: 5086-5092, 1997
16. Matsutani M: The Japanese Pediatric Brain Tumor Study Group: Combined chemotherapy and radiation therapy for CNS germ cell tumors-the Japanese experience. J Neurooncol 54: 311-316, 2001
17. Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T, Bates SE: Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes. Cancer Res 59: 8-13, 1999
18. Mohri M, Nitta H, Yamashita J: Expression of multidrug resistance-associated protein (MRP) in human gliomas. J Neurooncol 49: 105-115, 2000
19. Nagane M, Asai A, Shibui S, Nomura K, Matsutani M, Kuchino Y: Expression of O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea resistance of human brain tumos. Jpn J Clin Oncol 22: 143-149, 1992
20. Nakajima H, Iwai Y, Yamanaka K, Yasui T, Kishi H: Primary intracranial germinoma in the medulla oblongata. Surg Neurol 53: 448-451, 2000
21. Piwinca-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM: Functional imaging of mutidrug-resistance P glycoprotein with an organotechnetium complex. Cancer Res 53: 977-984, 1993
22. Sawamura Y, Shirato H, Ikeda J, Tada M, Ishii N, Kato T, Abe H, Fujieda K: Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma. J Neurosurg 88: 66-72, 1998
23. Shibamoto Y, Sasai K, Oya N, Hiraoka M: Intracranial germinoma: radiation therapy with tumor volume-based dose selection. Radiology 218: 452-456, 2001
24. Shibata Y, Matsumura A, Nose T: Effect of expression of P-glycoprotein on technetium-99m methoxyisobutylisonitrile single photon emission computed tomography of brain tumors. Neuro Med Chir (Tokyo) 42: 325-331, 2002
25. Shirato H, Nishio M, Sawamura Y, Myohjin M, Kitahara T, Nishioka T, Mizutani Y, Abe H, Miyasaka K: Analysis of long-term treatment of intracranial germinoma. Int J Radiat Oncol Biol Phys 37: 511-515, 1997
26. Tanaka S, Kamitani H, Amin MR, Watanabe T, Oka H, Fujii K, Nagashima T, Hori T: Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes. J Neurooncol 46: 157-171, 2000
27. Yokogami K, Kawano H, Moriyama T, Uehara H, Sameshima T, Oku T, Goya T, Wakisaka S, Nagamachi S, Jinnouchi S, Tamura S: Application of SPECT using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPECT? Eur J Nucl Med 25: 401-409, 1998